Publicacions en què col·labora amb Manuel Adolfo Sánchez Martín (16)

2009

  1. Cancer induction by restriction of oncogene expression to the stem cell compartment

    EMBO Journal, Vol. 28, Núm. 1, pp. 8-20

2008

  1. FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARγ and C/EBPα and activating elF4E

    PLoS ONE, Vol. 3, Núm. 7

2007

  1. Fat-specific FUS-DDIT3-transgenic mice establish PPARγ inactivation is required to liposarcoma development

    Carcinogenesis, Vol. 28, Núm. 10, pp. 2069-2073

  2. Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice

    Oncogene, Vol. 26, Núm. 12, pp. 1702-1713

2006

  1. SLUG (SNAI2) overexpression in embryonic development

    Cytogenetic and Genome Research, Vol. 114, Núm. 1, pp. 24-29

2005

  1. Cancer development induced by graded expression of Snail in mice

    Human Molecular Genetics, Vol. 14, Núm. 22, pp. 3449-3461

  2. SLUG in cancer development

    Oncogene, Vol. 24, Núm. 19, pp. 3073-3082

2003

  1. Deletion of the SLUG (SNAI2) gene results in human piebaldism

    American Journal of Medical Genetics, Vol. 122 A, Núm. 2, pp. 125-132

  2. The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug

    Oncogene, Vol. 22, Núm. 27, pp. 4205-4211

2002

  1. Aspectos actuales y previsiones de futuro de la terapia génica

    Medicine: Programa de Formación Médica Continuada Acreditado, Vol. 8, Núm. 82, pp. 4428-4437

  2. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice

    Oncogene, Vol. 21, Núm. 11, pp. 1679-1684

  3. SLUG (SNA12) deletions in patients with Waardenburg disease

    Human Molecular Genetics, Vol. 11, Núm. 25, pp. 3231-3236

  4. Understanding mesenchymal cancer: The liposarcoma-associated t(12;16) (q13;p11) chromosomal translocation as a model

    Current Genomics, Vol. 3, Núm. 4, pp. 237-244

  5. Zinc-finger transcription factor slug contributes to the function of the stem cell factor c-kit signaling pathway

    Blood, Vol. 100, Núm. 4, pp. 1274-1286

2001

  1. Selective destruction of tumor cells through specific inhibition of products resulting from chromosomal translocations

    Current Cancer Drug Targets, Vol. 1, Núm. 2, pp. 109-119

2000

  1. Liposarcoma initiated by FUS/TLS-CHOP: The FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma

    Oncogene, Vol. 19, Núm. 52, pp. 6015-6022